Episode Details
Back to Episodes
Ketamine Research for Treatment-Resistant Depression (Early Work Through Current State)
Published 6 years ago
Description
Roughly one in 10 Americans takes an antidepressant to aid in the debilitating symptoms of clinical depression, but for some medications don’t work. In this episode, Amit Anand, MD, discusses the evolving therapies for treatment-resistant depression, including ketamine and esketamine.
For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.